"/> Invitrogen™ Peptide synthétique SPTLC2 humain | B-LABO France

Invitrogen™ Peptide synthétique SPTLC2 humain

Réf. : BL-RE-175994Réf. fabricant : 15235259 50 μg
137,00 € HT

Synthetic Peptide

Gene ID (Entrez)
9517
Espèces
Human
Méthode de purification
purified
Numéro d’adhésion
O15270
Nom usuel
Human SPTLC2
Marque
Invitrogen

SPT2 Synthetic Peptide, PEP-1256, from Invitrogen.

Serine palmitoyltransferase (SPT), which consists of two different subunits, is the key enzyme in sphingolipid biosynthesis. It converts L-serine and palmitoyl-CoA to 3-oxosphinganine with pyridoxal 5'-phosphate as a cofactor. SPT2 is the long chain base subunit 2 of mammalian serine palmitoyltransferase. SPT2 is catalytically active but needs its related protein SPT1 for its stabilization and anchoring the holoenzyme to the cytosolic face of the endoplasmic reticulum. As in the case with SPT1, mutations in the SPT2 gene can cause hereditary sensory and autonomic neuropathy type I (HSAN-I), resulting from a loss of SPT activity as well as the accumulation of the atypical and neurotoxic sphingoid metabolite 1-deoxy-sphinganine.

Caractéristiques techniques

MarqueInvitrogen
Réf. B-LABOBL-RE-175994
Réf. fabricant15235259
Gene ID (Entrez)9517
EspècesHuman
Méthode de purificationpurified
Numéro d’adhésionO15270
Nom usuelHuman SPTLC2
Concentration200 μg/mL
Contenu et stockage-20°C
FormatLiquid
FormulePBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
À utiliser avec (application)Blocking Assay, Control
Symbole de gène(s)SPTLC2
LyophiliséNo
Conservateur0.02% sodium azide
Type de produitPeptide
Quantité50 μg
État réglementaireRUO - research use only
Tampon de stockagePBS
Une question, une configuration particulière ?
Contactez-nous pour un devis.